chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Obtunded, diaphoretic, LOC, distant heart and lung sounds, Patient given 0.3mg epinephrine IM and began to respond with weak voice to medical staff. Pt complained of chest pressure and painful respirations. Pt then transferred to hospital.
After the 2nd shot, she felt chills, her arm is nowhere near as sore, she felt tired but could not sleep all night long; After the 2nd shot, she felt chills, her arm is nowhere near as sore, she felt tired but could not sleep all night long; After the 2nd shot, she felt chills, her arm is nowhere near as sore, she felt tired but could not sleep all night long; her arm is nowhere near as sore; This is a spontaneous report from a contactable consumer (Patient). A female patient of an unspecified age (Age:76, Unit: unknown) received BNT162B2 (BNT162B2 Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Lot number: unknown, Expiration date: unknown), via an unspecified route of administration on an unspecified date 2nd dose, single for covid-19 immunization. Patient previously received BNT162B2 (BNT162B2 Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Lot number: unknown, Expiration date: unknown), via unspecified route on unspecified date at a 1ST DOSE, SINGLE, for COVID-19 immunization and after the 1st shot her arm got really sore, could not sleep that night. Medical history included insomnia from an unknown date and unknown if ongoing. The patients concomitant medications were not reported. On an unspecified date patient experienced events after the 2nd shot, she felt chills, her arm was nowhere near as sore, she felt tired but could not sleep all night long. She tried treatment with Melatonin and Benadryl but it 'worked backwards' on her. Reporter would like to know if the covid vaccine is known to keep one from sleeping and would like to know if her not being able to sleep would prevent the covid vaccine from working. Reporter would like to know if her side effects would prevent the covid vaccine from working. Outcome of all events was unknown.  Follow-up attempts are completed. No further information is expected.
After the vaccine I experienced fatigue. A few weeks after I had hand stiffness and swelling of joints in both hands. I had lab results in August 2021 that showed I have some high inflammation and low vitamin D. I'm still experiencing hand stiffness and swelling in both hands but the fatigue has gone away.
pt had mild swelling & patch of redness on thigh were inj given;sl burising;
4-6 hrs after receiving immunizations he started running fever which gradually increased to 104 rectal, had to be held and rocked due to unconsolable crying. Was back to normal w/in 24 hrs.
Infanrix administered pregnant patient; Infanrix administered to 28 y/o patient; Infanrix was given instead of Boostrix; This prospective pregnancy case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 28-year-old female patient who received DTPa (Infanrix) (batch number 49TM3, expiry date 28th May 2022) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 24th January 2022, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. The patient's last menstrual period was on an unknown date and estimated date of delivery was on an unknown date. The patient received Infanrix at an unknown time during the pregnancy. On 24th January 2022, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the patient experienced vaccine exposure during pregnancy. On an unknown date, the outcome of the inappropriate age at vaccine administration, wrong vaccine administered and vaccine exposure during pregnancy were unknown. The pregnancy was ongoing.   This report is made without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The case was reported by the care co-ordinator. The reporter stated that, Infanrix was administered to the pregnant patient instead of Boostrix, which led to inappropriate age at vaccine administration, wrong vaccine administered and vaccine exposure during pregnancy. The Healthcare professional gave permission for safety to follow up. The reporter consented to follow up.
I tested positive for COVID-19 on 12/5/22. I had extreme fatigue, cough, sore throat, and a fever of 102. I contacted my doctor, and she told me to go to urgent care. I went to urgent care, and they prescribed 5 days' worth of PAXLOVID. I am feeling much better now.
her arm hurt; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), for Covid-19 Immunization, reaction(s): "felt "under the weather"". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "her arm hurt".  Additional information:  Reporter mentioned as well that they took 2 Covid19 tests and the result was negative. She asks if it's okay for her to take a booster shot since she got exposed to her husband.  She stated that she had no symptoms but did not get tested. How long after him testing positive should she wait to get a booster dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Janssen COVID-19 Vaccine EUA - Fever & Insomnia 10 hours after injection.  Fever & Lethargy 20+ hours after injection.
Information has been received from a physician concerning a 16 month old male who on 7/29/98 was vaccinated with MMRII (lot 627427/0792H). Concomitant therapy (date unspecified) included the 1st dose of HIB (ActHib), IM in the left thigh (lot 0919800), the 3rd dose of oral poliovirus vaccine (Orimune) (lot 0786M4) and the 1st dose of DPT (Tripedia), IM in the left thigh (lot 0920770). On 8/7/98, the pt developed a maculo-papular rash. On 08/10/98, the pt was seen by his physician and some loose stool was noted. The physician indicated that the pt had an otherwise normal exam, was asymptomatic and that the rash could have been viral. No lab or diagnostic testing was done and the pt subsequently recovered. Additional information is not expected.
sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick). At the time of the report, ILLNESS (sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment Medications were not provided by the reporter.   Reporter did not allow further contact
I had a fever of 102.6 that lasted for 4 days, myalgia, nausea and a headache.
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/11/2021 and 4/01/2021.  PMHx significant for COPD heart failure and CKD3. Presented to ED on 11/16/2021 with shortness of breath for several days, noted to have severe respiratory distress with oxygen saturation in 50's requiring intubation in ED. CXR in ED confirmed pneumothorax requiring chest tube. Due to chronic lung disease and Covid-19 infx lung status remained poor with persistent air leak.  Family decided to withdraw life support on 11/19/2021.
Right after she received her second dose, she started to feel really dizzy and said her head was pounding.  It continued to get worse after 25 minutes.  Her mother said this has happened before with other vaccines that it aggravates her POTS.  Her mom said when this happens, she takes her to Children Hospital.  She took her to the hospital after she left the pharmacy for treatment.
temperature excursion; the ROTATEQ was administered two times; This spontaneous report was received from a nurse referring to a patient of unknown age and unknown gender. The patient's concurrent condition, medical history and concomitant therapy were not reported.       On 20-OCT-2020, hepatitis a vaccine, inactivated (VAQTA) (lot # T008697 with expiration date 04-JUN-2021), hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II), pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) and rotavirus vaccine, live, oral, pentavalent(ROTATEQ) ((lot # and expiration date were not provided) experienced a temperature excursion (incorrect product storage). The patient was vaccinated with the hepatitis a vaccine, inactivated (VAQTA) one time and rotavirus vaccine, live, oral, pentavalent(ROTATEQ) two times (dose and route were not provided) (inappropriate schedule of vaccine administered) for prophylaxis after the temperature excursion. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T008697; expirationdate: 04-JUN-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
This is a 39 year old male presents to clinic for follow up on COVID19 vaccine allergic reaction. Patient received the first dosage in the right deltoid on 12MAR21.  About 22 hours later, noticed right-side neck swelling and discomfort.  The next day 14MAR21, noticed right ear pain and jaw pain.  On 15Mar21, noticed right jaw pain/paresthesia and difficulty opening his mouth.  No dyspnea.  Went to ER on 15Mar21, observed, treated with Ibuprofen/Tylenol.   3weeks later, he went to the Block arena, was told get the second dose at the Tripler just in case of reaction, that he should be near the ER.  Spoke with an Allergist (at the COVID screening tent). He still had some numbness on his jaw. Was told to wait until symptoms clearance before the second shot.  Symptoms cleared by 2 weeks later. On 5/21/2021, he went to Covid tent.  Was told not to get the second shot.  He went to the facility. He seen the medical officer explained the situation.  He received the second shot on his right deltoid. He was observed for 30 min and did fine.  The next day, he had swelling of the right side of the neck for 4-5 days.  Subsided by 5th day.  He did not have ear or the jaw pain. Symptoms subsided and he felt normal. No concerns at this point.  No chest pain, dyspnea.  He can exercise without symptoms.
A 75 year old male patient received RSV Vaccine or Placebo and Influenza Vaccine on an unspecified date. The patient was admitted to the hospital on 3/10/03 for pneumonia (both lungs). The investigator assessed the event as possibly related to study product. Follow up information received on 4/3/03: The patient was put on antibiotic therapy and there is a good chance he will be going to a rehab center when he is discharged. Diagnosis: Pneumonia in both lungs. Follow up information received 6/20/03: Investigator spoke to family members who refused to provide any information on patient. Plan to request records from hospital.
On 12/30/14, client reported resolving local reaction (pain, redness, warmth) but complains of continuing joint pain in particular the left shoulder. She did not want to see a physician. Patient returned on Feb. 6th with the same complaint of joint soreness.  She has been receiving accupuncture treatments for this and still does not want to see a physician.
first dose 06Jan2020, second dose not administered; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 6th January 2020, batch number 3C3YW, expiry date 5th March 2022).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not believe the reason for delay was due to any supply issue. The reporter consented to follow up.
The initial shot wasn't bad. Sore arm within 5 hours. That's all I had, until Thursday evening at 6. Overwhelmed with exhaustion and fatigue. Massive headache coinciding. My arm felt like I had tennis elbow and overall joint pain. Nausea and vomiting through the night. Went to bed about 9:30. Woke up with a fever of 99. Off and on fever and chills through Friday, 72 hours after initial injection. Finally resolved late Friday night.
Day 1: Severe fatigue Day 2: Fatigue and difficulty regulating temperature (chills and sweats) Day 3: Fatigue and minor nasal drainage
pt recvd vax; devel fever, chills,gastritis manifested by n & v;HAs & weakness; Blood work pos for 2 types of TYP;tx w/ bactrim;repeat stool cultures were neg; MD not certain if sxs due to to TYP vax;
peppery tongue; scratchy throat; low grade fever of 99.0F; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE DISORDER (peppery tongue), THROAT IRRITATION (scratchy throat) and PYREXIA (low grade fever of 99.0F) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TONGUE DISORDER (peppery tongue), THROAT IRRITATION (scratchy throat) and PYREXIA (low grade fever of 99.0F). At the time of the report, TONGUE DISORDER (peppery tongue), THROAT IRRITATION (scratchy throat) and PYREXIA (low grade fever of 99.0F) outcome was unknown.            No relevant concomitant medications were reported. Treatment details were not reported by the reporter.
The pt was vaccinated with the Covid-19 vaccine, everything was mixed correctly.  Unfortunately, we missed calculated the 10-week BUD window and gave the vaccine outside the BUD by one day.  Spoke to the pt's parent.
Soreness at the site of injection; fatigue; This is a spontaneous report from a contactable consumer. A 50-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection; Lot number: EL3247), via an unspecified route of administration on 12Feb2021, 10:00 AM as single dose at Right arm for covid-19 immunisation. The patient medical history and concomitant medications included none. On 22Jan2021 patient taken the first dose. On 13Feb2021, the patient had Soreness at the site of injection and fatigue for 24-48 hours after administration. The outcome of event was Recovered.  No follow up attempts are possible. No further information is expected.
Fever chills, fever, gen pain, joint pain, soreness and swelling to injection site  Narrative:
injection site rash - started day 2- 2 inches x 3 inches; very painful to touch - no treatment, not resolved on day 3 (date reporting) headache - started day 1-2, deep behind eyes - took advil- resolved day 3 malaise - started day 2, resolved day 3
body pain; Pain during injection; left arm numbness; myalgia; hair hurts; headache; flu-like symptoms; nausea; This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number 4H9G2, expiry date 25th September 2021) for prophylaxis.   On 11th July 2019, the patient received the 1st dose of Shingrix (intramuscular). On 11th July 2019, immediately after receiving Shingrix, the patient experienced injection site pain, numbness of upper extremities, myalgia, hair disorder, headache, influenza-like symptoms and nausea. On an unknown date, the patient experienced general body pain. On an unknown date, the outcome of the injection site pain and general body pain were unknown and the outcome of the numbness of upper extremities, myalgia, hair disorder, headache, influenza-like symptoms and nausea were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, numbness of upper extremities, myalgia, hair disorder, headache, influenza-like symptoms, nausea and general body pain to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the left deltoid. The patient experienced pain during injection. By the night, on the day of vaccination, the patient experience whole left arm numbness which was currently milder. Less than a day, after vaccination with Shingrix, the patient experienced numbness of upper extremities, myalgia, hair disorder, headache, influenza like symptoms and nausea. At the time of reporting, whole body pain (myalgia), hair hurts, headache, flu like symptoms, and nausea were ongoing. The reporter consented to follow up.
Sore arm and chills started an hour after shot.  At 11pm the same day (12 hours after shot)  I woke up with severe diarrhea and some nausea but no vomiting.  After about 10 minutes it stopped briefly,  I felt better and went to bed.  5 minutes later it hit again.  It seemed to stop again and I felt better but as I walked from the bathroom to the furniture I blacked out and started losing consciousness.  My husband called paramedics and they took me to the ER.   They diagnosed it as a viral gastrointestinal and said it was likely a reaction to the vaccine.   I drank 80oz of water the day of the vaccine and at least 64 Oz per day leading up to the shot to make sure I was well hydrated.  Yet,  the severe diarrhea still caused some dehydration.   The ER gave me saline and anti nausea IV and sent me home.  I'm still weak and shaky today with headache but my arm is not as sore and I only had one episode of diarrhea with no blackouts.  I slept most of the day extremely fatigued.  No fever as of my last check tonight.
Felt flu-ish- stayed in my jammies for an entire week. Couldn't do anything. I had a horrible headache. super tired; (was exposed to COVID); I was fatigued and super hot and couldn't cool down. After my fifth day of feeling horrible, We were having a huge spike in COVID cases when I was experiencing this and so my friends in the doctor office - said to stay at home and quarantine. Had a Parking lot - COVID nasal test - swab in the very front and I tested negative - they couldn't go all the way to the back because of my bleeding disorder. He went maybe a quarter of an inch in my nostril. My son, 13, started experiencing the same symptoms. I took Excedrin Extra strength and also Nyquil both day and night time to help me feel better.  I had the symptoms probably 7-10 days total. We had such a huge uptake of cases here and I called the County and they said there were no testing sites available even. They were all full. They said if I experienced shortness of breath to go to the hospital.
No adverse event; instead of shingles vaccine (Shingrix) and the pharmacist in shift administered Moderna Bivalent COVID vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (instead of shingles vaccine (Shingrix) and the pharmacist in shift administered Moderna Bivalent COVID vaccine) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.   In September 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Feb-2023, received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (instead of shingles vaccine (Shingrix) and the pharmacist in shift administered Moderna Bivalent COVID vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (instead of shingles vaccine (Shingrix) and the pharmacist in shift administered Moderna Bivalent COVID vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (instead of shingles vaccine (Shingrix) and the pharmacist in shift administered Moderna Bivalent COVID vaccine).    No concomitant medications were reported. On 10Feb2023, patient came to receive the second dose of the shingles vaccine (Shingrix) and the pharmacist in shift administered Moderna Bivalent COVID vaccine.  The patient had already received this vaccine on Sep2022. No treatment medications were reported.
On 01/23/01, the child received her fourth injection of Infanrix. On that date, she also received injections of Varivax and IPOL. On 01/25/02, the vaccinee returned to the physician's office with "severe" swelling at the injection site "The area was very very red, hot and painful." The physician made a diagnosis of cellulitis. The physician stated that the event was moderate in intensity and related to Infanrix administration. The event resolved without medical intervention on 01/26/2002.
Confusion and disorientation in the morning following the injection. There were flu-like symptoms throughout the day including fever, vomiting, diarrhea, headache, and body aches. Treatment was a light diet, increased fluids and some Tylenol. I had several periods of heavy sweating as the fever broke overnight. I was tired but felt better the following morning.
woke with rash on neck, no itch,pain,fever, erythema on back of neck from ear to ear and to shirt line. no bites/scrtches/swelling. remaining skin within normal limits. treated with hydrocortisone cream 1%
Patient came into pharmacy with an appointment signed up on    The parent entered the appointment with the DOB of  on the site and attested that the information was true.   The mother returned on 11/15/21 to state that the child's birthday is actually  which would make her only 11 years old.   Since the child was thought to be12years old, they received the adolescent dose of 30mcg instead of the pediatric dose.  There have no reported adverse events or side effects.  The mother stated the child was doing well.  Consulted with Health Dept and stated for next dose patient can either receive pediatric dose in 3 weeks or wait till February and receive the adolescent dose.
pt recv vax 10OCT97 430PM & woke up crying 8PM began sz @ 830PM lasted for 6min;mom put child on one side as instructed prev by neurologist;T102.8;given diazapan p/awakening;